• #1085679
  • Sanofi Pasteur #49281041850

Fluzone® Quadrivalent 2018 - 2019 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL

FLUZONE 2018 QUAD, SYR 0.5ML (10DOSE/BX)

Features
  • Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Fluzone Quadrivalent is indicated for active immunization in persons 6 Months of age and older
  • Prefilled single-dose syringe (clear syringe plunger rod), 0.5 mL, for persons 36 months of age and older
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1085679
Manufacturer #49281041850
BrandFluzone® Quadrivalent 2018 - 2019
ManufacturerSanofi Pasteur
Country of OriginUnknown
ApplicationFlu Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number49281-0418-50
Product DatingMcKesson Acceptable Dating: we will ship >= 30 days
Storage RequirementsRequires Refrigeration
Strength60 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 6 Months of Age and Above
Volume0.5 mL
Features
  • Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • Fluzone Quadrivalent is indicated for active immunization in persons 6 Months of age and older
  • Prefilled single-dose syringe (clear syringe plunger rod), 0.5 mL, for persons 36 months of age and older
  • Fluzone Quadrivalent (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs
  • Fluzone Quadrivalent is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following four influenza strains recommended for the 2017-2018 influenza season: A/Michigan/45/2015 X-275 (H1N1), A/Hong Kong/4801/2014 X-263B (H3N2), B/Phuket/3073/2013 (B Yamagata lineage), and B/Brisbane/60/2008 (B Victoria lineage)
  • The single-dose, pre-filled syringe (0.25 mL and 0.5 mL) and the single-dose vial (0.5 mL) are manufactured and formulated without thimerosal or any other preservative
More Information